Evidence map›Paper›PMID 20534835›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2010

Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking.

Heinrich J G Matthies, Jessica L Moore, Christine Saunders, Dawn Signor Matthies, Lynne A Lapierre, James R Goldenring, Randy D Blakely, Aurelio Galli

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. CaJournal of chemical neuroanatomy · 2017
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2013
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Heinrich J G MatthiesDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. heinrich.j.matthies@vanderbilt.edu
Jessica L Moore
Christine Saunders
Dawn Signor Matthies
Lynne A Lapierre
James R Goldenring
Randy D Blakely
Aurelio Galli
Vanderbilt University · USCenter for Neurosciences · USInstitute of Molecular Biology and Biophysics · RUUniversity School of Nashville · US

Funding

Amphetamine Regulation of Dopamine TransportR01DA013975 · NIDA · VANDERBILT UNIVERSITY · PI GALLI, AURELIO · 2001 to 2010
$2.8M
Amphetamine Regulation of Dopamine TransportR56DA013975 · NIDA · VANDERBILT UNIVERSITY · PI GALLI, AURELIO · 2012 to 2013
$688k
NIDA NIH HHS DA13975NIDA NIH HHS R01 DA013975NIDA NIH HHS R56 DA013975NIMH NIH HHS MH05892
6 · The paper itself

Abstract

The norepinephrine transporter (NET) is a presynaptic plasma membrane protein that mediates reuptake of synaptically released norepinephrine. NET is also a major target for medications used for the treatment of depression, attention deficit/hyperactivity disorder, narcolepsy, and obesity. NET is regulated by numerous mechanisms, including catalytic activation and membrane trafficking. Amphetamine (AMPH), a psychostimulant and NET substrate, has also been shown to induce NET trafficking. However, neither the molecular basis nor the nature of the relevant membrane compartments of AMPH-modulated NET trafficking has been defined. Indeed, direct visualization of drug-modulated NET trafficking in neurons has yet to be demonstrated. In this study, we used a recently developed NET antibody and the presence of large presynaptic boutons in sympathetic neurons to examine basal and AMPH-modulated NET trafficking. Specifically, we establish a role for Rab11 in AMPH-induced NET trafficking. First, we found that, in cortical slices, AMPH induces a reduction in surface NET. Next, we observed AMPH-induced accumulation and colocalization of NET with Rab11a and Rab4 in presynaptic boutons of cultured neurons. Using tagged proteins, we demonstrated that NET and a truncated Rab11 effector (FIP2DeltaC2) do not redistribute in synchrony, whereas NET and wild-type Rab11a do. Analysis of various Rab11a/b mutants further demonstrates that Rab11 regulates NET trafficking. Expression of the truncated Rab11a effector (FIP2DeltaC2) attenuates endogenous Rab11 function and prevented AMPH-induced NET internalization as does GDP-locked Rab4 S22N. Our data demonstrate that AMPH leads to an increase of NET in endosomes of single boutons and varicosities in a Rab11-dependent manner.

Indexed as

Adrenergic AgentsAmphetamineAnimalsBiotinylationCarrier ProteinsCells, CulturedFluorescent Antibody TechniqueGanglia, SympatheticMembrane ProteinsMiceMice, Inbred C57BLMicroscopy, ConfocalMutationNeuronsNorepinephrine Plasma Membrane Transport ProteinsProtein TransportAdrenergic AgentsAmphetamineCarrier ProteinsMembrane ProteinsNorepinephrine Plasma Membrane Transport ProteinsRab11fip2 protein, ratrab11 GTP-Binding Proteinsrab4 GTP-Binding Proteinsrab GTP-Binding Proteins

Identifiers

PMID20534835
PMCPMC2935280
OpenAlexW2010153547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.